Boxing, backflipping robots rule at China's biggest AI summit
The more popular robots were the creations of Unitree, UBTech Robotics Corp and Agibot, who've built up some name-recognition among the hundreds of startups and big tech firms vying to produce the world's most advanced humanoid androids. The scores of machines on display were the most visible symbol yet of China's surprisingly rapid ascent in a key arena of artificial intelligence. Hangzhou-based Unitree teased an entry-level US$6,000 (RM25,437) droid and ByteDance Ltd posted a video of its Mini hanging up a shirt just days before the World Artificial Intelligence Conference kicked off over the weekend.
"The technology is developing so fast,' Deep Robotics' Americas director Eric Wang told Bloomberg Television. But "so far, in the US market, we don't see very cost-effective and reliable competitors. And we don't see that happening in two to three years.'
Chinese upstarts are pushing the boundaries of what's possible within a technological sphere that inspires fear and awe in equal measure. From EngineAI to Leju, little-known names drive a field in which American companies like Boston Dynamics have so far failed to stake out a clear lead despite years of effort. In 2025 alone, humanoids ran a half-marathon, competed in a kick-boxing tournament and played football. Even if those events weren't exactly technology triumphs – most of the participants stumbled, fumbled or failed to complete the race – each underscored the country's ambitions.
A robot prepares coffee in a stand during the World Artificial Intelligence Conference (WAIC) at the Shanghai World Expo and Convention Center in Shanghai on July 28, 2025. — AFP
Widespread integration into daily life remains a distant prospect, perhaps as much as a decade away by some estimates. "It looks lively and bustling, but it's all for show on the stage,' Alex Zhou, a Qiming Venture partner, said of the conference when he asked two startup founders about use cases during a Monday panel.
Yet the advances unfolding in China and elsewhere are reshaping the industry landscape, with humanoid robots poised to play an expanding role across factory floors, hospitals and households. Citigroup Inc predicts a US$7 trillion (RM29.68 trillion) humanoid robot market by 2050, which China is racing to dominate.
Hundreds of robotics startups have taken root following President Xi Jinping's endorsement of the sector and a plethora of incentives. Domestically made semiconductors and open-source AI models are hastening the pace. But not every startup is expected to survive in a cash-hungry sector where, additionally, the humans building robots remain in short supply.
"We've talked to more founders this year – the sheer amount of competition we have – is more than what we have in the past two years combined,' said Tim Wang, co-founder of startup investor Monolith Management, which backs DeepSeek. "A lot of these companies are not going to exist five years down the road. But I think the entire concept of a healthy frenzy is very good for the industry to develop.'
Beyond the high-tech display, China's robotics industry is grappling with its own contradictions.
The country faces an urgency to integrate robots into work and daily lives. A demographic decline and shortage of factory workers is threatening its manufacturing dominance. Robots, specifically human-looking ones, may be one answer.
"Even with huge challenges, more breakthroughs are expected in the coming couple of years or even months ahead,' Wu Bi, a technical lead at Deep Touch, said in front of a statue of the Greek goddess Aphrodite that was speaking perfect Chinese. – Bloomberg
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
25 minutes ago
- The Star
Tasco likely to post stronger earnings on its new warehouse
MBSB Research said it has kept its earnings projections unchanged. PETALING JAYA: Stronger quarters are envisaged for Tasco Bhd , given improved contributions from its new warehouse and substantial tax savings recognition once investments under the integrated logistics services tax incentives are approved, says MBSB Research. The logistics group posted a net profit of RM19.9mil for the first quarter of financial year 2026 (1Q26), up 30.68% year-on-year, thanks to stronger earnings contribution from its international business solutions (IBS) segment. MBSB Research, formerly MIDF Research, said Tasco's 1Q26 results had met its expectations, with margin recovery starting to take shape. 'We have kept our earnings projections unchanged. 'We anticipate further improvement in the contract logistics segment this financial year, driven by recent additions to its customer base.' Notably, the logistics-based group is largely shielded from tariff-related risks, with the US-bound volumes accounting for less than 5% of its total revenue. The research house had maintained a 'buy' call on the stock with an unchanged target price of 68 sen. Meanwhile, RHB Research, in a note to clients, said better performance in the group's IBS segment was dragged by weaker domestic business solutions (DBS) segment in 1Q26. It noted 1Q26 core profit was also missed on a weaker DBS segment due to slower volume and higher costs. However, the research house said it remained optimistic for stronger quarters ahead on improved contributions from the new warehouse and substantial tax savings. For now, RHB Research had made no changes to its forecasts on Tasco, pending the group's upcoming analysts briefing. 'At this juncture, we remain upbeat for the upcoming quarters of financial year 2026 (FY26), driven by volume recovery, stronger contributions from new warehouses, and higher tax savings,' the research house noted. RHB Research has kept a 'buy' call on the stock with a target price of 86 sen.
Malaysian Reserve
34 minutes ago
- Malaysian Reserve
Health Gorilla Joins CMS-Aligned Network as a Trusted Data Network Enabling AI-Ready Clinical Data Exchange
CORAL GABLES, Fla., July 30, 2025 /PRNewswire/ — Health Gorilla, a designated Qualified Health Information Network (QHIN) under the Trusted Exchange Framework and Common Agreement (TEFCA), today announced its participation as one of the inaugural data network early adopters in the CMS-Aligned Network. Recognized by the Centers for Medicare & Medicaid Services (CMS) as a trusted exchange partner, Health Gorilla brings a unique capability to the initiative: enabling secure, standards-based access to AI-ready structured clinical data at national scale. Unveiled at a White House convening of over 30 leading healthcare and technology organizations, the CMS-Aligned Network represents a foundational step toward a more connected, patient-centric health data ecosystem. Health Gorilla's Chief Operating Officer, Patrick Lane, attended the event on behalf of the company. 'The CMS-Aligned Network sets the stage for a new era of healthcare,' said Patrick Lane, President and Chief Operating Officer at Health Gorilla. 'As a TEFCA-designated QHIN, we not only support trusted exchange—we deliver deduplicated, normalized, and AI-ready data that patient-facing app developers, payers, and providers need to build tools that actually improve care. That's the difference we bring to this initiative.' Enabling Intelligent Interoperability Across the CMS Health Tech Ecosystem As one of the first operational QHINs and a CMS-recognized data network, Health Gorilla offers: AI-Ready Data at Scale – Health Gorilla transforms raw clinical records into structured, normalized, and deduplicated data—delivered through secure FHIR APIs to power advanced analytics, decision support, and intelligent applications. FHIR-Native, TEFCA-Compliant Exchange – Enabling real-time data sharing across payers, providers, public health agencies, and digital health platforms, all aligned with national policy and technical frameworks. Trusted Infrastructure for Ecosystem Builders – Supporting secure digital identity, provider directory resolution, and consented access to complete patient records—all foundational elements of CMS's long-term vision. By participating in the CMS-Aligned Network, Health Gorilla will also support CMS's ability to engage in trusted exchange by 2026, enabling data access for beneficiaries and providers through modern, secure digital channels. 'In today's landscape, it's not just about connecting data—it's about making it usable, trustworthy, and intelligent,' Lane added. 'We're proud to deliver the infrastructure and the data quality that the CMS Health Tech Ecosystem will rely on.' About Health Gorilla Health Gorilla, a designated QHIN under TEFCA, is a leading national interoperability platform delivering secure, real-time access to structured, AI-ready health data. Health Gorilla supports EHR vendors, value-based care organizations, and digital health innovators with data-driven workflows that enable more informed, connected, and efficient care. Media Contact:Grace VintonAmendola for Health Gorilla203-561-8935gvinton@
The Star
42 minutes ago
- The Star
Frontken expected to report solid 2Q results
HLIB Research said favourable foreign-exchange trends and sustained strong demand from its key Taiwanese clients will drive the company's growth. PETALING JAYA: Frontken Corp Bhd , a provider of support services to the semiconductor industry, is expected to record a strong financial performance in its second quarter of 2025 (2Q25) on strong tailwinds from macro factors, analysts say. Favourable foreign-exchange trends and sustained strong demand from its key Taiwanese clients will drive its growth, said Hong Leong Investment Bank Research (HLIB Research). Frontken stands to benefit from the surge in new semiconductor fabs globally, notably in the United States, Singapore and India, while the weaker ringgit against the Taiwanese dollar works in its favour, the research house said. The Taiwanese dollar appreciated against the ringgit by 4% in 2Q25 from the previous consecutive quarter. But a dilution in the company's share base is expected to cap share prices for the time being. 'While we remain positive on Frontken's growth prospects, a potential sizeable increase in share count of an additional 32% from a warrant conversion that expires in May 2026 remains an overhang that could limit upside in the near term,' the research house said. 'With Frontken's share price now above the RM4 warrant exercise price, the 510 million in-the-money warrants (32% of the current share base) could present a near-term overhang. 'Sustained re-rating beyond the current price range would require strong catalysts such as unexpected strong earnings delivery, clear expansion plans or entry into new markets to absorb incremental supply,' the research house added. HLIB Research also said Frontken is holding some US$30mil in cash that was previously intended for a potential US acquisition, which could result in up to some RM10mil in non-core, unrealised forex losses in 2Q25. The weaker ringgit bodes well for Frontken's key subsidiary, Ares Green Tech Corp, which primarily bills its customers in the Taiwanese dollar, the research house said. 'This contrasts with other listed Malaysian peers in the technology sector that are affected by the stronger ringgit due to their US dollar-based export sales,' it said. HLIB Research said although the planned US acquisition did not materialise, the country's market remains on Frontken's radar, with management currently exploring a potential joint venture or collaboration with a US-based precision cleaning company to support Taiwan Semiconductor Manufacturing Co Ltd's newly established fabs. 'In the near term, cleaning services are still handled in Taiwan via air freight, which remains cost-effective relative to the high operating costs in the United States. However, this arrangement is unlikely to be sustainable, as it runs counter to US localisation and self-sufficiency objectives.' HLIB Research left its forecasts for Frontken unchanged, maintaining its 'hold' call with an unchanged target price of RM4, based on a target price-earnings ratio of 35 times earnings for next year.
